SIBO protocol — what supplements actually help small intestinal bacterial overgrowth
Small intestinal bacterial overgrowth (SIBO) is a clinical diagnosis built on a constellation of bloating, post-prandial distension, and altered bowel habit, typically with a positive lactulose or glucose breath test. The supplement layer in SIBO is unusual: most of "gut health" — probiotics and prebiotics — performs poorly or actively worsens symptoms by adding bacteria or fermentable substrate to a small bowel already overgrown. The supplement evidence converges on three areas: targeted botanical antimicrobials (one trial directly compared to rifaximin), prokinetics, and digestive enzymes/HCl support. Recurrence is the dominant clinical problem — addressing the underlying cause is mandatory.
For SIBO, supplements are an adjunct to a confirmed diagnosis and treatment of the underlying cause — not a substitute for either. The unusual twist is that most "gut health" products hurt here: probiotics and fermentable prebiotics tend to feed an already-overgrown small bowel. The strongest supplement evidence is for botanical antimicrobials — in the Chedid 2014 study the herbal protocols matched rifaximin (46% vs 34% eradication) — with prokinetics like ginger and artichoke used afterward to fight the high recurrence rate. The key caveat: confirm SIBO with a breath test and address the driver (PPI use, motility, prior surgery), since symptom-only "SIBO" overlaps heavily with IBS and other conditions that need different treatment.
Get tested before treating. "SIBO" diagnosed only by symptoms massively overlaps IBS, fructose intolerance, sucrase-isomaltase deficiency, bile-acid diarrhoea, and food chemical sensitivities — all of which respond to different interventions. Lactulose or glucose hydrogen/methane breath testing has limitations but is the standard objective test. Persistent or unexplained symptoms (weight loss, anaemia, fat malabsorption) need gastroenterology evaluation; SIBO supplements are not a substitute for working up the underlying cause (motility disorder, structural issue, prior bowel surgery, scleroderma, hypochlorhydria).
What actually has trial evidence
Herbal antimicrobial protocol — Chedid 2014 combinations
FC Cidal (Quintessence) + Dysbiocide (Biotics Research) 2 capsules b.i.d. × 4 weeks, OR Candibactin-AR + Candibactin-BR (Metagenics) 2 capsules b.i.d. × 4 weeks
The Chedid 2014 retrospective open-label study (n=104) directly compared these two herbal protocols to rifaximin 1200 mg/day × 10 days in SIBO. Eradication rates: herbal 46%, rifaximin 34% (not statistically different). This is one of the only studies in any context to show botanical antimicrobials in a head-to-head with the gold-standard antibiotic. The protocols contain berberine, allicin, oregano, thyme, wormwood, and other established antimicrobial botanicals. 4 weeks is the minimum trial duration.
Allicin (stabilised garlic extract)
450 mg b.i.d.–t.i.d. of stabilised allicin extract for 4 weeks
For methane-positive SIBO (intestinal methanogen overgrowth, IMO), Pimentel's centre has used allicin clinically as adjunct to rifaximin, with the Allimax-type stabilised allicin form. Mechanism: direct inhibition of methanogens (Methanobrevibacter smithii). Avoid garlic if FODMAP-sensitive — concentrated allicin extract has minimal FODMAP load compared to whole garlic.
Berberine (with phytosomal absorption-enhanced if available)
500 mg t.i.d. for 4 weeks
Berberine has broad antimicrobial activity in vitro and is a long-standing folk and Ayurvedic antimicrobial. Used at 500 mg t.i.d. for SIBO; included in many herbal antimicrobial stacks. Also has glycaemic and lipid effects which can be desirable side benefits. Stop 1 week before any methylene blue / coumarin use; possible CYP interactions.
Ginger + artichoke (Iberogast / Motility Activator) or low-dose erythromycin (Rx)
Ginger 1 g/day + artichoke leaf extract 320 mg/day at bedtime, after eradication
SIBO recurrence is driven by impaired migrating motor complex (MMC) — the housekeeping wave that sweeps the small bowel between meals. Prokinetics support MMC integrity. Ginger and artichoke (the Iberogast / Motility Activator combination) have small trial evidence in functional dyspepsia and SIBO recurrence. Spacing meals 4+ hours apart (no constant snacking) is essential for MMC function regardless of supplement use.
Betaine HCl with pepsin (in confirmed low stomach acid)
Test dose 650 mg with meal containing protein; titrate to mild warmth, then back off 1 capsule
Hypochlorhydria (often PPI-induced or age-related) is an underrecognised SIBO driver. Betaine HCl supplementation can help if low gastric acid is the predisposing factor. Self-test cautiously and not in users with active ulcers, gastritis, or on NSAIDs/aspirin. Conservative escalation; stop if any burning sensation.
The lifestyle and behavioural base — most important for recurrence
- Identify and address the underlying cause — SIBO almost always has a driver: PPI use, prior abdominal surgery (especially appendectomy or cholecystectomy), connective tissue disease, dysmotility (diabetic gastroparesis), narcotic use, structural issues. Treating SIBO without addressing the cause produces a relapse cycle.
- Meal spacing — 4-hour gaps between meals to allow MMC firing; snacking constantly blocks the housekeeping wave.
- Targeted dietary restriction during treatment — low-FODMAP, SIBO-specific diet, or bi-phasic diet during eradication phase. Lift restriction after eradication; long-term restriction starves protective species.
- PPI deprescribing — if PPI was the trigger, taper with prescriber. H2 blockers and intermittent use are often acceptable substitutes.
- Hydration and physical activity — both support gut motility.
- Vagal tone work — humming, gargling, slow breathing — small but consistent evidence in functional GI disorders.
What to skip
- Generic Lactobacillus/Bifidobacterium probiotics — adds bacteria to a small bowel already overgrown. Some Lactobacillus species directly produce D-lactate in SIBO with neurological symptoms.
- Inulin, FOS, fructooligosaccharides, GOS prebiotics — fermentable substrate that feeds the overgrowth. Avoid during active SIBO.
- "Gut healing" 30-ingredient stacks with L-glutamine + zinc + slippery elm + marshmallow + DGL + curcumin — diluted ingredients, no SIBO-specific trial data, often with prebiotic substrate that worsens symptoms.
- Kombucha, kefir, sauerkraut, fermented foods during active SIBO — additional fermentable substrate; reintroduce after eradication.
- Apple cider vinegar as "stomach acid" — acidity insufficient to replace HCl; primarily anecdotal.
- "Colon hydrotherapy" or saline lavage — no SIBO evidence; small bowel is not addressed.
- Long-term elemental diet without supervision — the elemental diet (Vivonex) has clinical evidence in SIBO eradication but requires medical supervision; not a supplement to start on your own.
What to track
Symptom diary: bloating severity (0–10), post-prandial distension timing, stool form (Bristol), and number of bowel movements/day. Repeat lactulose or glucose breath test at 4–8 weeks after eradication if available. The clinical bar: bloating <3/10 most days, stool form Bristol 3–4, and absence of post-prandial distension. Recurrence is common (30–50% at 9 months in some series); ongoing prokinetic support and underlying-cause management is the recurrence-prevention strategy.
Practical quick-start. Confirm SIBO with a hydrogen/methane breath test before treating. Identify and address the driver (PPI, motility, structural). Eradication phase: rifaximin (Rx) is the standard of care, particularly for moderate-to-severe symptoms; the herbal protocols (Chedid combinations or Candibactin AR+BR) at 4 weeks are an alternative with meaningful evidence. Methane-dominant: add neomycin or allicin to rifaximin. Prevention phase: meal spacing, address driver, prokinetic if recurrence-prone. Work with a clinician comfortable with SIBO management.
Sources
- Chedid V, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16–24. PMID: 24891990
- Pimentel M, et al. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165–178. PMID: 32023228
- Rezaie A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112(5):775–784. PMID: 28323273
- Lauritano EC, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103(8):2031–2035. PMID: 18802998
- Pittman N, et al. Plant-derived antimicrobials in the treatment of small intestinal bacterial overgrowth. Integr Med (Encinitas). 2014;13(1):24–32.
- Pimentel M, et al. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004;49(1):73–77. PMID: 14992438